Announcements Trials
Browse Landscape

Phase

Phase 4 3Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1

Conditions

Polycystic Ovary Syndrome 3Weight Loss 2Prediabetic State 1Obesity, Abdominal 1Obesity 1Insulin Resistance 1Infertility, Female 1Glucose Intolerance 1

Interventions

Metformin 4Exenatide 2semaglutide 1lime 1dapagliflozin 1Taxes 1Tamoxifen 1Surveys and Questionnaires 1Sugars 1Sugammadex 1Sodium-Glucose Transporter 2 Inhibitors 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Qsymia 1Paclitaxel 1Liraglutide 1Letrozole 1Immunoenzyme Techniques 1Glucagon-Like Peptide 1 1Early Intervention, Educational 1Diazoxide 1Counseling 1Carboplatin 1Brachytherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Obesity × Liraglutide × Clear all
NCT05952882 2023-10-23

Liraglutide and Metformin Combination on Weight Loss, Metabolic - Endocrine Parameters and Pregnancy Rate in Women With PCOS, Obesity and Infertility

Mỹ Đức Hospital

Phase 3 Unknown
188 enrolled
Other

Infertility, Female, Insulin Resistance, Obesity, Polycystic Ovary Syndrome, Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon ⚡